Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1887) 1887
osteonecrosis - chemically induced (1765) 1765
science & technology (1375) 1375
life sciences & biomedicine (1359) 1359
diphosphonates - adverse effects (1038) 1038
female (1007) 1007
male (869) 869
bone density conservation agents - adverse effects (856) 856
jaw diseases - chemically induced (803) 803
middle aged (629) 629
dentistry (621) 621
osteonecrosis (506) 506
aged (487) 487
biological and medical sciences (464) 464
medical sciences (460) 460
necrosis (447) 447
adult (443) 443
bones (430) 430
dentistry, oral surgery & medicine (418) 418
risk factors (399) 399
abridged index medicus (329) 329
surgery (327) 327
diseases of the osteoarticular system (286) 286
osteonecrosis - pathology (284) 284
animals (272) 272
bisphosphonates (272) 272
vascular bone diseases (262) 262
pharmacology. drug treatments (260) 260
diphosphonates - administration & dosage (255) 255
diphosphonates - therapeutic use (250) 250
imidazoles - adverse effects (230) 230
bone density conservation agents - administration & dosage (221) 221
bone density conservation agent (214) 214
osteonecrosis - diagnosis (214) 214
oncology (212) 212
aged, 80 and over (208) 208
osteoporosis (206) 206
bone density conservation agents - therapeutic use (197) 197
osteoporosis - drug therapy (193) 193
orthopedics (187) 187
osteonecrosis - surgery (186) 186
osteonecrosis - prevention & control (183) 183
femur head necrosis - chemically induced (182) 182
bone neoplasms - drug therapy (177) 177
osteonecrosis - diagnostic imaging (173) 173
adolescent (169) 169
glucocorticoids - adverse effects (164) 164
retrospective studies (163) 163
osteonecrosis - therapy (160) 160
mandibular diseases - chemically induced (158) 158
bones, joints and connective tissue. antiinflammatory agents (154) 154
osteonecrosis - epidemiology (151) 151
treatment outcome (150) 150
bone neoplasms - secondary (149) 149
care and treatment (148) 148
follow-up studies (148) 148
otorhinolaryngology. stomatology (147) 147
time factors (146) 146
radiography (143) 143
diphosphonates (140) 140
adrenal cortex hormones - adverse effects (139) 139
jaw (137) 137
magnetic resonance imaging (137) 137
medicine & public health (137) 137
multiple myeloma - drug therapy (135) 135
rheumatology (132) 132
antineoplastic agents - adverse effects (121) 121
administration, oral (120) 120
child (118) 118
general & internal medicine (114) 114
disease models, animal (113) 113
incidence (113) 113
medicine, general & internal (112) 112
cancer (108) 108
jaw diseases - therapy (108) 108
jaw diseases - prevention & control (107) 107
bisphosphonate (106) 106
health aspects (106) 106
injections, intravenous (106) 106
jaw diseases - pathology (105) 105
phosphonates (105) 105
rabbits (101) 101
alendronate - adverse effects (99) 99
endocrinology & metabolism (98) 98
osteonecrosis of the jaw (96) 96
maxillary diseases - chemically induced (92) 92
breast neoplasms - drug therapy (90) 90
osteonecrosis - drug therapy (89) 89
tooth extraction - adverse effects (87) 87
drug therapy (86) 86
dose-response relationship, drug (85) 85
jaw diseases - epidemiology (85) 85
corticosteroids (84) 84
analysis (78) 78
zoledronic acid (78) 78
bisphosphonate-associated osteonecrosis of the jaw - etiology (76) 76
jaw diseases - diagnosis (76) 76
denosumab (73) 73
imidazoles - administration & dosage (73) 73
research (72) 72
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1915) 1915
French (67) 67
German (44) 44
Japanese (31) 31
Spanish (25) 25
Portuguese (14) 14
Italian (12) 12
Dutch (11) 11
Chinese (10) 10
Hungarian (10) 10
Russian (9) 9
Norwegian (8) 8
Danish (5) 5
Czech (4) 4
Hebrew (4) 4
Croatian (3) 3
Polish (2) 2
Swedish (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Corticosteroids in Lupus
by Kasturi, Shanthini and Sammaritano, Lisa R
Rheumatic diseases clinics of North America, ISSN 0889-857X, 2016, Volume 42, Issue 1, pp. 47 - 62
Prednisone | Corticosteroids | Systemic lupus erythematosus | Glucocorticoids | Methylprednisolone | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Glucocorticoids - therapeutic use | Osteoporosis - chemically induced | Cataract - chemically induced | Osteoporosis - therapy | Comorbidity | Lupus Erythematosus, Systemic - epidemiology | Humans | Cardiovascular Diseases - therapy | Glaucoma - chemically induced | Peptic Ulcer - epidemiology | Adrenal Cortex Hormones - therapeutic use | Infection - chemically induced | Peptic Ulcer - therapy | Diabetes Mellitus - epidemiology | Diabetes Mellitus - therapy | Hypertension - chemically induced | Lupus Erythematosus, Systemic - drug therapy | Cardiovascular Diseases - epidemiology | Diabetes Mellitus - chemically induced | Cardiovascular Diseases - chemically induced | Muscular Diseases - chemically induced | Osteonecrosis - chemically induced | Peptic Ulcer - chemically induced | Osteoporosis - epidemiology
Journal Article
Details down arrow
2. Full Text Long-Term Use of Bisphosphonates in Osteoporosis
by Watts, Nelson B and Diab, Dima L
The journal of clinical endocrinology and metabolism, ISSN 0021-972X, 04/2010, Volume 95, Issue 4, pp. 1555 - 1565
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Atrial Fibrillation - chemically induced | Bone Density Conservation Agents - pharmacokinetics | Esophageal Neoplasms - chemically induced | Bone Density Conservation Agents - adverse effects | Humans | Bone Density Conservation Agents - therapeutic use | Diphosphonates - pharmacokinetics | Osteoporosis - drug therapy | Clinical Trials as Topic | Long-Term Care | Pain - chemically induced | Bone Density Conservation Agents - pharmacology | Jaw Diseases - chemically induced | Fractures, Bone - etiology | Osteoporosis - complications | Kidney Diseases - chemically induced | Diphosphonates - therapeutic use | Osteonecrosis - chemically induced | Diphosphonates - adverse effects | Diphosphonates - pharmacology | Fractures, Bone - prevention & control | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Side effects of drugs on the oral cavity
by Bascones-Martínez, Antonio and Muñoz-Corcuera, Marta and Bascones-Ilundain, Cristina
Medicina clínica, ISSN 0025-7753, 02/2015, Volume 144, Issue 3, pp. 126 - 131
Drugs | Oral cavity | Adverse reaction | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Disease Susceptibility | Tongue Diseases - chemically induced | Vasoconstrictor Agents - adverse effects | Halitosis - chemically induced | Humans | Pigmentation Disorders - chemically induced | Sialometaplasia, Necrotizing - chemically induced | Gingival Diseases - chemically induced | Hemorrhagic Disorders - chemically induced | Stomatitis - etiology | Opportunistic Infections - etiology | Mouth Diseases - chemically induced | Stomatitis - chemically induced | Immunosuppressive Agents - adverse effects | Salivary Gland Diseases - chemically induced | Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology | Taste Disorders - chemically induced | Mouth Diseases - pathology | Xerostomia - chemically induced
Journal Article
Details down arrow
4. Full Text Bisphosphonate-induced osteonecrosis of the jaw: A review of 2,400 patient cases
by Filleul, O and Crompot, E and Saussez, S
Journal of cancer research and clinical oncology, ISSN 0171-5216, 08/2010, Volume 136, Issue 8, pp. 1117 - 1124
Osteonecrosis of the jaws | Bisphosphonates | Epidemiology | Retrospective | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Vascular bone diseases | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Diseases of the osteoarticular system | Osteonecrosis - therapy | Humans | Male | Mandibular Diseases - surgery | Maxilla - surgery | Osteonecrosis - pathology | Maxillary Diseases - chemically induced | Bone Remodeling - drug effects | Osteitis Deformans - chemically induced | Sex Ratio | Jaw Diseases - chemically induced | Osteonecrosis - surgery | Maxillary Diseases - pathology | Jaw Diseases - pathology | Diphosphonates - therapeutic use | Maxillary Diseases - surgery | Female | Mandibular Diseases - chemically induced | Mandibular Diseases - pathology | Retrospective Studies | Osteonecrosis - chemically induced | Maxilla - pathology | Diphosphonates - adverse effects | Osteoporosis | Pharmacy | Phosphonates | Mars (Planet) | Bones | Universities and colleges | Metastasis | Health aspects | Necrosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Glucocorticoids and Rheumatoid Arthritis
by Ferreira, Joana Fonseca and Ahmed Mohamed, Alaa Abdelkhalik and Emery, Paul
Rheumatic diseases clinics of North America, ISSN 0889-857X, 2016, Volume 42, Issue 1, pp. 33 - 46
Drug-drug interactions | Glucocorticoids | Dose | Rheumatoid arthritis | Prednisolone | Side effect | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Glucocorticoids - administration & dosage | Osteoporosis - chemically induced | Administration, Oral | Atherosclerosis - chemically induced | Humans | Infections - chemically induced | Injections, Intramuscular | Dose-Response Relationship, Drug | Drug Interactions | Osteoporotic Fractures - chemically induced | Arthritis, Rheumatoid - drug therapy | Injections, Intra-Articular | Cardiovascular Diseases - chemically induced | Maintenance Chemotherapy | Diabetes Mellitus, Type 2 - chemically induced | Osteonecrosis - chemically induced | Weight Gain
Journal Article
Details down arrow
6. Glucocorticoid-Induced Osteoporosis and Osteonecrosis
by Weinstein, Robert S
Endocrinology and metabolism clinics of North America, ISSN 0889-8529, 09/2012, Volume 41, Issue 3, pp. 595 - 611
Glucocorticoid-induced apoptosis | Osteoclasts | Osteocytes | Denosumab | Bisphosphonates | Bone vascularity | Osteoblasts | Teriparatide | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Osteocytes - drug effects | Teriparatide - therapeutic use | Apoptosis - drug effects | Humans | Male | Osteoporosis - drug therapy | Osteoporotic Fractures - etiology | Bone and Bones - drug effects | Osteonecrosis - drug therapy | Antibodies, Monoclonal, Humanized - pharmacology | Bone and Bones - metabolism | Diphosphonates - therapeutic use | Female | Osteoporosis - physiopathology | Glucocorticoids - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Osteoporosis - chemically induced | Teriparatide - pharmacology | Osteocytes - metabolism | Osteoblasts - drug effects | Osteoporotic Fractures - prevention & control | Bone Density Conservation Agents - therapeutic use | Bone Density Conservation Agents - pharmacology | Osteonecrosis - chemically induced | Drug Monitoring | Osteoblasts - metabolism | Osteonecrosis - physiopathology | Diphosphonates - pharmacology
Journal Article
Details down arrow
7. Full Text Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment
by Marx, Robert E and Sawatari, Yoh and Fortin, Michel and Broumand, Vishtasb
Journal of oral and maxillofacial surgery, ISSN 0278-2391, 2005, Volume 63, Issue 11, pp. 1567 - 1575
Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Otorhinolaryngology. Stomatology | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Diseases of the osteoarticular system | Biological and medical sciences | Vascular bone diseases | Medical sciences | Jaw Diseases - diagnosis | Humans | Jaw Diseases - therapy | Bone Neoplasms - secondary | Dexamethasone - adverse effects | Male | Osteoporosis - drug therapy | Antineoplastic Agents - therapeutic use | Abscess - complications | Osteopetrosis - chemically induced | Tooth Extraction - adverse effects | Jaw Diseases - chemically induced | Multiple Myeloma - drug therapy | Drug Interactions | Antineoplastic Agents - adverse effects | Dental Caries - complications | Diphosphonates - therapeutic use | Abscess - therapy | Female | Bone Neoplasms - drug therapy | Diphosphonates - adverse effects | Prostatic Neoplasms - drug therapy | Hyperostosis - therapy | Osteonecrosis - diagnosis | Prostatic Neoplasms - pathology | Osteonecrosis - therapy | Bone Density Conservation Agents - adverse effects | Dental Caries - therapy | Multiple Myeloma - complications | Imidazoles - adverse effects | Risk Factors | Periodontitis - therapy | Bone Density Conservation Agents - therapeutic use | Osteopetrosis - therapy | Bone Neoplasms - complications | Breast Neoplasms - drug therapy | Hyperostosis - complications | Breast Neoplasms - complications | Alendronate - adverse effects | Dexamethasone - therapeutic use | Breast Neoplasms - pathology | Osteopetrosis - diagnosis | Periodontitis - complications | Prostatic Neoplasms - complications | Osteonecrosis - chemically induced | Surgery, Plastic | Diphosphonates | Index Medicus | Abridged Index Medicus | Dentistry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Role of coagulopathy in glucocorticoid-induced osteonecrosis of the femoral head
by Zhang, Qiankun and L v, Jin and Jin, Lie
6/2018, Volume 46, Issue 6, 8
femoral head | ischaemia | osteonecrosis | coagulopathy | Glucocorticoid | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Lipid Metabolism Disorders - physiopathology | Apoptosis - drug effects | Humans | Femur Head - blood supply | Femur Head Necrosis - physiopathology | Femur Head Necrosis - prevention & control | Endothelial Cells - physiology | Glucocorticoids - adverse effects | Femur Head Necrosis - etiology | Blood Platelet Disorders - chemically induced | Blood Coagulation Disorders - chemically induced | Hematologic Diseases - chemically induced | Lipid Metabolism Disorders - chemically induced | Anticoagulants - therapeutic use | Femur Head - physiopathology | Ischemia - physiopathology | Femur Head Necrosis - chemically induced | Animals | Hematologic Diseases - physiopathology | Platelet Activation - drug effects | Apoptosis - physiology | Endothelial Cells - pathology | Ischemia - chemically induced | Blood Coagulation Disorders - physiopathology | Endothelial Cells - drug effects | Apoptosis | Index Medicus | Reviews
Book Review
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Glucocorticoid-induced osteonecrosis
by Weinstein, Robert S and Weinstein, Robert S
Endocrine, ISSN 1355-008X, 4/2012, Volume 41, Issue 2, pp. 183 - 190
Avascular necrosis | Medicine & Public Health | Glucocorticoids | Internal Medicine | Osteocytes | Osteonecrosis | Diabetes | Osteoblasts | Bisphosphonates | Endocrinology | Science, general | Apoptosis | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Osteocytes - drug effects | Osteonecrosis - diagnosis | Osteonecrosis - etiology | Apoptosis - drug effects | Humans | Bone Density Conservation Agents - therapeutic use | Dexamethasone - adverse effects | Alendronate - therapeutic use | Osteonecrosis - drug therapy | Animals | Anti-Inflammatory Agents - adverse effects | Adult | Osteonecrosis - chemically induced | Glucocorticoids - adverse effects | Complications and side effects | Bones | Care and treatment | Corticosteroids | Diagnosis | Necrosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Levamisole-induced necrosis of skin, soft tissue, and bone: Case report and review of literature
by Ching, Jessica A and Smith Jr, David J
Journal of burn care & research, ISSN 1559-047X, 01/2012, Volume 33, Issue 1, pp. e1 - e5
Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Dermatology | Surgery | Science & Technology | Follow-Up Studies | Agranulocytosis - chemically induced | Humans | Middle Aged | Vasculitis, Leukocytoclastic, Cutaneous - chemically induced | Male | Fever - chemically induced | Fever - physiopathology | Soft Tissue Injuries - surgery | Cocaine-Related Disorders - complications | Cocaine - adverse effects | Agranulocytosis - pathology | Debridement - methods | Vasculitis, Leukocytoclastic, Cutaneous - pathology | Levamisole - adverse effects | Severity of Illness Index | Risk Assessment | Combined Modality Therapy | Skin Transplantation - methods | Necrosis - surgery | Soft Tissue Injuries - pathology | Vasculitis, Leukocytoclastic, Cutaneous - surgery | Necrosis - chemically induced | Osteonecrosis - surgery | Soft Tissue Injuries - chemically induced | Wound Healing - physiology | Osteonecrosis - chemically induced | Drug Contamination | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients
by Sonis, Stephen T and Watkins, Brynmor A and Lyng, Gregory D and Lerman, Mark A and Anderson, Kenneth C
Oral oncology, ISSN 1368-8375, 2008, Volume 45, Issue 2, pp. 164 - 172
Otolaryngology | Hematology, Oncology and Palliative Medicine | Jaw | Animal model | Osteonecrosis | Bisphosphonates | Dental extractions | Oncology | Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Biological and medical sciences | Medical sciences | Otorhinolaryngology. Stomatology | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Tumors | Injections, Intravenous | Prospective Studies | Imidazoles - administration & dosage | Dexamethasone - adverse effects | Osteonecrosis - pathology | Oral Ulcer - chemically induced | Bone Diseases, Metabolic - drug therapy | Jaw Diseases - chemically induced | Maxillary Diseases - pathology | Jaw Diseases - pathology | Female | Mandibular Diseases - chemically induced | Diphosphonates - adverse effects | Disease Models, Animal | Dexamethasone - administration & dosage | Bone Density Conservation Agents - adverse effects | Imidazoles - adverse effects | Rats | Diphosphonates - administration & dosage | Bone Density Conservation Agents - administration & dosage | Maxillary Diseases - chemically induced | Rats, Sprague-Dawley | Animals | Mandibular Diseases - pathology | Oral Ulcer - pathology | Osteonecrosis - chemically induced | Apoptosis | Medical colleges | Care and treatment | Cancer patients | Dexamethasone | Diphosphonates | Multiple myeloma | Bones | Necrosis | Cancer | Steroids | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights